Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
about
Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factorsAlcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms.TNFα is involved in neuropathic pain induced by nucleoside reverse transcriptase inhibitor in rats.The Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain.Nucleoside reverse transcriptase inhibitor usage and the incidence of peripheral neuropathy in HIV/AIDS patients.Brain-derived neurotrophic factor modulates antiretroviral-induced mechanical allodynia in the mouse.
P2860
Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
@ast
Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
@en
Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
@nl
type
label
Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
@ast
Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
@en
Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
@nl
prefLabel
Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
@ast
Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
@en
Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
@nl
P2093
P2860
P1433
P1476
Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
@en
P2093
Chennebault JM
Lafeuillade A
Mussini JM
Reliquet V
P2860
P356
10.1046/J.1468-1293.2001.00066.X
P577
2001-04-01T00:00:00Z